arrow
Back
H

Hang Quach

university of melbourne

39H-index
466Paper Count
1.2WCitation Count
Published Papers 79
Publication Date
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis
errLeukemia
IF13.4
err2026-08-24
err0
errOAAI
errThierry Facon; Shaji K. Kumar; Robert Z. Orlowski; Nizar Bahlis; Philippe Moreau; Hartmut Goldschmidt; Supratik Basu; Cyrille Hulin; Sonja Zweegman; Katja Weisel; Aurore Perrot; Caroline Jacquet; Noopur Raje; Salomon Manier; Ajai Chari; Markus Hansson; Mohamad Mohty; Michel Delforge; Torben Plesner; Gordon Cook; Xavier Leleu; Hang Quach; Christopher P. Venner; Mourad Tiab; Margaret Macro; Laurent Frenzel; George Wang; Huiling Pei; Kasey Bolyard; Robin Carson; Fredrik Borgsten; Saad Z. Usmani
errShare
errSave
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
err2025-12-27
err0
errOAAI
errGurdeep Parmar; Marcelo Capra; Fernanda Seguro; Vania Hungria; Meletios-Athanasios Dimopoulos; Sosana Delimpasi; Jiří Minařík; Ivan Špička; Luděk Pour; Herlander Marques; Graça Esteves; Kazutaka Sunami; Junichiro Yuda; Roman Hájek; Jana Mihályová; Christine Soufflet; Disa Yu; Khadija Benlhassan; Victorine Koch; Erin Comerford; Paul Cordero; Florence Suzan; Hang Quach
errShare
errSave
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
err2025-12-01
err2
PREAI
errKumar, Shaji; Mateos, Maria-Victoria; Ye, Jing Christine; Atrash, Shebli; Magen, Hila; Quach, Hang; Chu, Michael P.; Trudel, Suzanne; Richter, Joshua; Rodriguez-Otero, Paula; Chuah, Hun; Gatt, Moshe; Medvedova, Eva; Raza, Shahzad; Yoon, Dok Hyun; Ishida, Tadao; Matous, Jeffrey V.; Rosinol, Laura; Onodera, Koichi; Scott, Emma; Heuck, Christoph; Zhang, Jenny; Henninger, Todd; O'Rourke, Lisa; Thakkar, Payal; Festa, Mariacristina; Huang, Lin; Zhou, Jiangxiu; Takamoto, Mikihiro; Pei, Lixia; Lu, Jiashen; Au, Nicholas; Krevvata, Maria; Usmani, Saad Z.; Cohen, Yael C.
errShare
errSave
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
err2025-11-08
err0
PREAI
errSueh-li Lim; Cameron Wellard; Rajeev Rajagopal; Simon J. Harrison; Amit Khot; Hang Quach; Phoebe J. Ho; Elizabeth Moore; Erica Wood; Andrew Spencer
errShare
errSave
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial
err2025-11-03
err0
PREAI
errMeletios A Dimopoulos; Meral Beksac; Ludek Pour; Sosana Delimpasi; Vladimir Vorobyev; Hang Quach; Ivan Spicka; Jakub Radocha; Paweł Robak; Kihyun Kim; Michele Cavo; Kazuhito Suzuki; Jodie Wilkes; Simon McNamara; Amy Phillips-Jones; Kristin Morris; Farrah Pompilus; Molly Purser; Neal Sule; Brandon Kremer; Angely Loubert; Laurine Bunod; Manal M’Hari; Xiaoou L Zhou; Giulia Fulci; María-Victoria Mateos; Suzanne Trudel
errShare
errSave
New Zealand multiple myeloma patients demonstrate inferior outcomes when compared to Australian counterparts – a retrospective cohort study from the Myeloma and Related Diseases Registry (MRDR).
err2025-10-20
err0
errOAAI
errJian Li; Yayehirad Melsew; Cameron Wellard; Elizabeth M Moore; P. Joy Ho; Hang Quach; Simon J Harrison; Rajeev Rajagopal; Bradley Augustson; Erica M Wood; Andrew Spencer
errShare
errSave
Real-world comparison of treatment outcomes for multiple myeloma in elderly transplant ineligible patients receiving first-line VRd, Rd and VCd: Results from the Australian and New Zealand Myeloma and Related Diseases Registry
err2025-08-09
err0
errOAAI
errSarah Zhao; Cameron Wellard; Elizabeth M Moore; Andrew Spencer; Hang Quach; P. Joy Ho; Emma-Jane McDonald; Peter Mollee; Simon J Harrison; Bradley Augustson; Erica M Wood; Zoe K McQuilten; Rajeev Rajagopal
errShare
errSave
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
err2025-08-07
err0
errOAAI
errMaría-Victoria Mateos; Suzanne Trudel; Hang Quach; Paweł Robak; Meral Beksac; Ludek Pour; Marek Hus; Kihyun Kim; Vera Zherebtsova; Sosana Delimpasi; Tomas Jelínek; Christopher Ward; P. Joy Ho; Vladimir Vorobyev; Marcelo Pitombeira de Lacerda; Gracia Aparecida-Martinez; Ivan Spicka; Jakub Radocha; Michele Cavo; Claudio Cerchione
errShare
errSave
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events
err2025-07-28
err0
errOAAI
errEvangelos Terpos; Suzanne Trudel; María-Victoria Mateos; Nicolás Alejandre; Kathryn Colby; Meletios A. Dimopoulos; Simona Degli Esposti; Asim V. Farooq; Maria Gavriatopoulou; Francesca Gay; Vania Hungria; K. Martin Kortüm; Xavier Leleu; Sagar Lonial; Hang Quach; Lugui Qiu; Karthik Ramasamy; Kazuhito Suzuki; Katja C. Weisel; Paul Richardson
errShare
errSave
Plain language summary on subcutaneous administration of isatuximab in people with relapsed and/or refractory multiple myeloma
err2025-07-16
err0
errOAAI
errHang Quach; Gurdeep Parmar; Enrique M. Ocio; Miles Prince; Albert Oriol; Nobuhiro Tsukada; Pierre Bories; Disa Yu; Florence Suzan; Philippe Moreau
errShare
errSave
EXCALIBER-RRMM: a phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed/refractory multiple myeloma
err2025-05-10
err0
errOAAI
errLonial, Sagar; Dimopoulos, Meletios A.; Berdeja, Jesus G.; Richardson, Paul G.; Quach, Hang; Maciag, Paulo; Hong, Kevin; Amatangelo, Michael; Chen, Min; van de Donk, Niels W. C. J.
errShare
errSave
Real-World Use of carfilzomib-lenalidomide-dexamethasone (KRd) and carfilzomib-dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: A Prospective Multicenter Observational Study
err2025-05-07
err0
errOAAI
errHang Quach; Kihyun Kim; Raymond Siu Ming Wong; Si Yun Melinda Tan; Ming-Chung Wang; Kopei Chang; Megan Braunlin; Mihaela Talpes; Rani Najdi; Jin Seok Kim
errShare
errSave
Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
err2025-01-21
err0
errOAAI
errHo, P. Joy; Quach, Hang; Sidiqi, M. Hasib; Lee, Cindy H.; Butler, Jason; Spencer, Andrew; Micklethwaite, Kenneth; Li, Jingya; Cusson, Elissa; Bagnall, Robert; Harrison, Simon J.
errShare
errSave
Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma
err2024-11-07
err0
errOAAI
errZhao, Jessie; Khong, Tiffany; Gorniak, Malgorzata; Khaled, Abir; Mcdonald, Zac; Reynolds, John; Mithraprabhu, Sridurga; Bingham, Nicholas; Lim, Suehli; Wong, Daniel; Johnston, Anna; Motorna, Olga; Murphy, Nicholas; Quach, Hang; Yang, Liqiang; Spencer, Andrew
errShare
errSave
Biomarker Correlates and Clinical Activity of Cevostamab in Patients (pts) with Triple-Class Refractory Multiple Myeloma (MM) Who Have Received ≥1 Prior B-Cell Maturation Antigen (BCMA)-Targeted Bispecific Antibody (BsAb): Results from the Phase I/II CAMMA 2 Study
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errDelforge, Michel; Richter, Joshua; Cohen, Yael C.; Corradini, Paolo; Sborov, Douglas W.; Lesokhin, Alexander M.; Berdeja, Jesus G.; Gatt, Moshe E.; Paris, Laura; Dachs, Laura Rosinol; Quach, Hang; Kanwar, Manisha; Catalani, Olivier; Sewpaul, Paresh; Wassner-Fritsch, Elisabeth; Mishra, Ameet; Trunzer, Kerstin; Kumar, Shaji
errShare
errSave
Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errGration, Betty; Wellard, Cameron; Moore, Elizabeth; Tan, Marianne; Murphy, Matthew; Lim, Kenneth J. C.; Rowland, James; Hamad, Nada; Rajagopal, Rajeev; Mollee, Peter; Spencer, Andrew; Quach, Hang; Mccaughan, Georgia
errShare
errSave
Initial Results from the Frailty-Stratified, Randomised Controlled Bayesian Adaptive Trial of Bortezomib Versus Lenalidomide in Transplant Ineligible Myeloma (TI-NDMM)- the FRAIL-M Study (AMaRC 19-01; ALLG MM22)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errLim, Sueh-Li; Reynolds, John; Pemberton, Lucy; Wright, Tricia; Lee, Sophie Hyesuk; Mollee, Peter; Shetty, Anita C.; Weston, Helen; Byard, Nina; Le, Khoa; Mcquilten, Zoe K.; Quach, Hang; Spencer, Andrew
errShare
errSave
Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients
err2024-11-01
err1
PREAI
errLim, Kenneth J. C.; Wellard, Cameron; Moore, Elizabeth; Ninkovic, Slavisa; Chng, Wee Joo; Spencer, Andrew; Mollee, Peter; Hocking, Jay; Ho, Phoebe Joy; Janowski, Wojt; Kim, Kihyun; Mccaughan, Georgia; Dun, Karen; Mcquilten, Zoe K.; Chen, Fiona; Quach, Hang
errShare
errSave
Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
err2024-10-21
err0
errOAAI
errPopat, Rakesh; Augustson, Bradley; Gironella, Mercedes; Lee, Cindy; Cannell, Paul; Patel, Nashita; Kasinathan, Ravi S.; Rogers, Rachel; Shaikh, Mehreen; Curry, Amy; Carreno, Fernando; Roy-Ghanta, Sumita; Opalinska, Joanna; Quach, Hang
errShare
errSave